Skip to main content
Top
Published in: Journal of Cancer Education 2/2018

01-04-2018

Awareness and Knowledge Levels of Turkish College Students about Human Papilloma Virus Infection and Vaccine Acceptance

Authors: Murat Oz, Nilufer Cetinkaya, Aysen Apaydin, Elmas Korkmaz, Sevda Bas, Emre Ozgu, Tayfun Gungor

Published in: Journal of Cancer Education | Issue 2/2018

Login to get access

Abstract

Awareness of HPV by the target population is an important determinant of vaccine acceptance. The aim of this study is to evaluate the awareness of HPV infection and acceptability of the HPV vaccines among Turkish college students. College students aged 18–30 who were attending a large public university in Ankara participated in this study. The participants were asked to complete a questionnaire to elicit demographic characteristics, awareness level of HPV and HPV vaccine, and willingness to be vaccinated. One thousand one hundred sixty students responded to the invitation email and completed the questionnaire. The mean scores of female students about HPV and HPV vaccine were 7.1/15 and 3.6/9, respectively, while these scores were 7.9/15 and 3.4/9 among male students, respectively. While 51 % percent of female and 33.5 % of male students had heard of HPV and 32.8 % and 18 % of them had heard of HPV vaccine, respectively, only 1.5 % of female and 0.4 % of male students had been vaccinated against HPV. A total of 507 students (43.7 %) had previously heard of HPV. Only 309 (26.6 %) of the participants had previously heard of the HPV vaccine, and 45.1 % of the students were willing to receive HPV vaccination. The main predictors for willingness to be vaccinated were the following: sexual experience, sexual behavior, past history of sexually transmitted infection (STI), and knowledge about HPV and HPV vaccine. Higher awareness levels of HPV and HPV vaccine are significantly related to greater willingness to be vaccinated, and the main reasons for rejecting the vaccine were insufficient information about the vaccine and possible unknown side effects.
Literature
1.
go back to reference de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7):453–459CrossRefPubMed de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7):453–459CrossRefPubMed
2.
go back to reference Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL (2012) The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 206(1):46 e1–46e11CrossRef Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL (2012) The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 206(1):46 e1–46e11CrossRef
3.
go back to reference Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS et al (2015) Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecol Oncol 137(1):47–54CrossRefPubMed Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS et al (2015) Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecol Oncol 137(1):47–54CrossRefPubMed
4.
go back to reference Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32(Suppl 1):S16–S24 Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32(Suppl 1):S16–S24
5.
go back to reference Castellsague X (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 110(3 Suppl 2):S4–S7CrossRefPubMed Castellsague X (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 110(3 Suppl 2):S4–S7CrossRefPubMed
6.
go back to reference Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819CrossRefPubMed Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819CrossRefPubMed
7.
go back to reference Vardas E, Giuliano AR, Goldstone S, Palefsky JM, ED M Jr, Penny ME et al (2011) External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 203(1):58–65CrossRefPubMedCentralPubMed Vardas E, Giuliano AR, Goldstone S, Palefsky JM, ED M Jr, Penny ME et al (2011) External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 203(1):58–65CrossRefPubMedCentralPubMed
8.
go back to reference Glick SN, Feng Q, Popov V, Koutsky LA, Golden MR (2014) High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis 209(3):369–376CrossRefPubMed Glick SN, Feng Q, Popov V, Koutsky LA, Golden MR (2014) High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis 209(3):369–376CrossRefPubMed
9.
go back to reference Zou H, Tabrizi SN, Grulich AE, Garland SM, Hocking JS, Bradshaw CS et al (2014) Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis 209(5):642–651CrossRefPubMed Zou H, Tabrizi SN, Grulich AE, Garland SM, Hocking JS, Bradshaw CS et al (2014) Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis 209(5):642–651CrossRefPubMed
10.
go back to reference Sadlier C, Rowley D, Higgins D, Sheils O, Bergin C (2014) Human papillomavirus (HPV) and the usefulness of the HPV vaccine for men who have sex with men. J Infect Dis 210(10):1679CrossRefPubMed Sadlier C, Rowley D, Higgins D, Sheils O, Bergin C (2014) Human papillomavirus (HPV) and the usefulness of the HPV vaccine for men who have sex with men. J Infect Dis 210(10):1679CrossRefPubMed
11.
go back to reference Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A (2009) Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 9:191CrossRefPubMedCentralPubMed Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A (2009) Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 9:191CrossRefPubMedCentralPubMed
12.
go back to reference Dursun P, Ayhan A, Mutlu L, Caglar M, Haberal A, Gungor T et al (2013) HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg 29(3):210–216PubMed Dursun P, Ayhan A, Mutlu L, Caglar M, Haberal A, Gungor T et al (2013) HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg 29(3):210–216PubMed
13.
go back to reference Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S et al (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International journal of cancer Journal international du cancer 131(10):2349–2359CrossRefPubMed Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S et al (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International journal of cancer Journal international du cancer 131(10):2349–2359CrossRefPubMed
14.
go back to reference Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19(8):531–538CrossRefPubMedCentralPubMed Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19(8):531–538CrossRefPubMedCentralPubMed
15.
go back to reference Klug SJ, Hukelmann M, Blettner M (2008) Knowledge about infection with human papillomavirus: a systematic review. Prev Med 46(2):87–98CrossRefPubMed Klug SJ, Hukelmann M, Blettner M (2008) Knowledge about infection with human papillomavirus: a systematic review. Prev Med 46(2):87–98CrossRefPubMed
16.
go back to reference Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK (2011) The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87(7):544–547CrossRefPubMed Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK (2011) The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87(7):544–547CrossRefPubMed
17.
go back to reference Kim JJ, Goldie SJ (2009) Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 339:b3884CrossRefPubMedCentralPubMed Kim JJ, Goldie SJ (2009) Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 339:b3884CrossRefPubMedCentralPubMed
18.
go back to reference Jit M, Brisson M, Portnoy A, Hutubessy R (2014) Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health 2(7):e406–e414CrossRefPubMed Jit M, Brisson M, Portnoy A, Hutubessy R (2014) Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health 2(7):e406–e414CrossRefPubMed
19.
go back to reference Patel H, Jeve YB, Sherman SM, Moss EL (2016) Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review. Sex Transm Infect. doi:10.1136/sextrans-2015-052341 Patel H, Jeve YB, Sherman SM, Moss EL (2016) Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review. Sex Transm Infect. doi:10.​1136/​sextrans-2015-052341
20.
go back to reference Kwang NB, Mahayudin T, Yien HL, Abdul Karim AK, Teik CK, Shan LP (2016) Effect of an educational intervention on knowledge of human papillomavirus vaccination among pre-university students in Malaysia. Asian Pacific journal of cancer prevention: APJCP 17(1):267–274CrossRefPubMed Kwang NB, Mahayudin T, Yien HL, Abdul Karim AK, Teik CK, Shan LP (2016) Effect of an educational intervention on knowledge of human papillomavirus vaccination among pre-university students in Malaysia. Asian Pacific journal of cancer prevention: APJCP 17(1):267–274CrossRefPubMed
21.
go back to reference Dell DL, Chen H, Ahmad F, Stewart DE (2000) Knowledge about human papillomavirus among adolescents. Obstet Gynecol 96(5 Pt 1):653–656PubMed Dell DL, Chen H, Ahmad F, Stewart DE (2000) Knowledge about human papillomavirus among adolescents. Obstet Gynecol 96(5 Pt 1):653–656PubMed
22.
go back to reference Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J et al (2014) Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014—United States. MMWR Morb Mortal Wkly Rep 63(29):620–624PubMedCentralPubMed Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J et al (2014) Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014—United States. MMWR Morb Mortal Wkly Rep 63(29):620–624PubMedCentralPubMed
24.
go back to reference Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB (2012) Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 130(5):798–805CrossRefPubMed Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB (2012) Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 130(5):798–805CrossRefPubMed
25.
go back to reference Schiller JT, Castellsague X, Garland SMA (2012) Review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123–F138CrossRefPubMedCentralPubMed Schiller JT, Castellsague X, Garland SMA (2012) Review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123–F138CrossRefPubMedCentralPubMed
26.
go back to reference Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Levesque LE (2015) The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics 135(5):e1131–e1140CrossRefPubMed Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Levesque LE (2015) The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics 135(5):e1131–e1140CrossRefPubMed
27.
go back to reference Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S et al (2011) Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 29(47):8591–8598CrossRefPubMed Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S et al (2011) Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 29(47):8591–8598CrossRefPubMed
28.
go back to reference Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J (2012) Interest in having HPV vaccination among adolescent boys in England. Vaccine 30(30):4505–4510CrossRefPubMed Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J (2012) Interest in having HPV vaccination among adolescent boys in England. Vaccine 30(30):4505–4510CrossRefPubMed
29.
go back to reference Blodt S, Holmberg C, Muller-Nordhorn J, Rieckmann N (2012) Human papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Pub Health 22(6):808–813CrossRef Blodt S, Holmberg C, Muller-Nordhorn J, Rieckmann N (2012) Human papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Pub Health 22(6):808–813CrossRef
30.
go back to reference Ratanasiripong NT, Cheng AL, Enriquez M (2013) What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine. Vaccine 31(10):1370–1376CrossRefPubMed Ratanasiripong NT, Cheng AL, Enriquez M (2013) What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine. Vaccine 31(10):1370–1376CrossRefPubMed
31.
go back to reference Caskey R, Lindau ST, Alexander GC (2009) Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. The Journal of adolescent health: official publication of the Society for Adolescent Medicine 45(5):453–462CrossRef Caskey R, Lindau ST, Alexander GC (2009) Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. The Journal of adolescent health: official publication of the Society for Adolescent Medicine 45(5):453–462CrossRef
32.
go back to reference Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S et al (2009) Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women’s Health 18(10):1679–1686CrossRef Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S et al (2009) Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women’s Health 18(10):1679–1686CrossRef
33.
go back to reference Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD (2010) Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health 10:27CrossRefPubMedCentralPubMed Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD (2010) Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health 10:27CrossRefPubMedCentralPubMed
34.
go back to reference Wheldon CW, Daley EM, Buhi ER, Nyitray AG, Giuliano AR (2011) Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine 29(45):8060–8065CrossRefPubMed Wheldon CW, Daley EM, Buhi ER, Nyitray AG, Giuliano AR (2011) Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine 29(45):8060–8065CrossRefPubMed
36.
go back to reference Roberts ME, Gerrard M, Reimer R, Gibbons FX (2010) Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics 125(5):982–989CrossRefPubMed Roberts ME, Gerrard M, Reimer R, Gibbons FX (2010) Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics 125(5):982–989CrossRefPubMed
37.
go back to reference Gottvall M, Tyden T, Hoglund AT, Larsson M (2010) Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS 21(8):558–562CrossRefPubMed Gottvall M, Tyden T, Hoglund AT, Larsson M (2010) Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS 21(8):558–562CrossRefPubMed
Metadata
Title
Awareness and Knowledge Levels of Turkish College Students about Human Papilloma Virus Infection and Vaccine Acceptance
Authors
Murat Oz
Nilufer Cetinkaya
Aysen Apaydin
Elmas Korkmaz
Sevda Bas
Emre Ozgu
Tayfun Gungor
Publication date
01-04-2018
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 2/2018
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1116-0

Other articles of this Issue 2/2018

Journal of Cancer Education 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine